These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
206 related items for PubMed ID: 3512535
1. A comparison of parenteral loxapine and haloperidol in hostile and aggressive acutely schizophrenic patients. Tuason VB. J Clin Psychiatry; 1986 Mar; 47(3):126-9. PubMed ID: 3512535 [Abstract] [Full Text] [Related]
2. A double-blind comparison between loxapine and haloperidol by parenteral route in acute schizophrenia. Paprocki J, Versiani M. Curr Ther Res Clin Exp; 1977 Jan; 21(1):80-100. PubMed ID: 12922 [No Abstract] [Full Text] [Related]
9. Loxapine versus chlorpromazine in paranoid schizophrenia: a double-blind study. Tuason VB, Escobar JI, Garvey M, Schiele B. J Clin Psychiatry; 1984 Apr; 45(4):158-63. PubMed ID: 6370967 [Abstract] [Full Text] [Related]
10. Parenteral haloperidol for rapid control of severe, disruptive symptoms of acute schizophrenia. Reschke RW. Dis Nerv Syst; 1974 Mar; 35(3):112-5. PubMed ID: 17894080 [Abstract] [Full Text] [Related]
11. Loxapine succinate: a controlled double-blind study in chronic schizophrenia. Schiele BC. Dis Nerv Syst; 1975 Jul; 36(7):361-4. PubMed ID: 1097221 [Abstract] [Full Text] [Related]
12. Loxapine succinate as initial treatment of hostile and aggressive schizophrenic criminal offenders. Feldman HS. J Clin Pharmacol; 1982 Jul; 22(8-9):366-70. PubMed ID: 7130427 [Abstract] [Full Text] [Related]
13. The efficacy and safety of loxapine succinate in the treatment of schizophrenia: a comparative study with thiothixene. Vianna Filho U, Versiani Caldeira V, Romildo Bueno J. Curr Ther Res Clin Exp; 1975 Sep; 18(3):476-90. PubMed ID: 810308 [No Abstract] [Full Text] [Related]
14. Comparison of injectable molindone and haloperidol followed by oral dosage forms in acutely ill schizophrenics. Escobar JI, Mann JJ, Keller J, Wilkins J, Mason B, Mills MJ. J Clin Psychiatry; 1985 Aug; 46(8 Pt 2):15-9. PubMed ID: 3894337 [Abstract] [Full Text] [Related]
15. Treatment of acute psychotic patients with loxapine parenterally. Fruensgaard K, Jensen K. Curr Ther Res Clin Exp; 1976 Feb; 19(2):164-9. PubMed ID: 813953 [No Abstract] [Full Text] [Related]
16. A double-blind controlled study of intramuscular zuclopenthixol acetate and liquid oral haloperidol in the treatment of schizophrenic patients with acute exacerbation. Chouinard G, Safadi G, Beauclair L. J Clin Psychopharmacol; 1994 Dec; 14(6):377-84. PubMed ID: 7884017 [Abstract] [Full Text] [Related]
17. [Loxapine succinate: a new neuroleptic]. Cottereau MJ, Poirier MF, Lôo H, Deniker P. Encephale; 1979 Dec; 5(3):251-67. PubMed ID: 39739 [Abstract] [Full Text] [Related]
18. A double-blind comparison of loxitane--loxapine succinate and trifluoperazine hydrochloride in chronic schizophrenic patients. Moyano CZ. Dis Nerv Syst; 1975 Jun; 36(6):301-4. PubMed ID: 238810 [Abstract] [Full Text] [Related]
19. Plasma/RBC haloperidol ratios and improvement in acute psychotic symptoms. Neborsky RJ, Janowsky DS, Perel JM, Munson E, Depry D. J Clin Psychiatry; 1984 Jan; 45(1):10-3. PubMed ID: 6363395 [Abstract] [Full Text] [Related]
20. [Clinical trial of loxapine succinate in the treatment of 30 cases of psychotic states]. Escande M, Granier F, Gardes JP, Boscredon J, Concina M. Ann Med Psychol (Paris); 1983 Mar; 141(3):309-22. PubMed ID: 6357022 [Abstract] [Full Text] [Related] Page: [Next] [New Search]